Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase pseudogene 5 (PAICSP5) is a nonfunctional genetic element classified as a pseudogene. Pseudogenes are sequences in the genome that are similar to known genes but typically do not encode functional proteins due to mutations, deletions, or lack of necessary regulatory elements. PAICSP5 is related by sequence to genes encoding enzymes involved in purine biosynthesis (specifically, phosphoribosylaminoimidazole carboxylase and succinocarboxamide synthetase), but it does not express these enzymes and is not a target for drugs or considered in disease association or therapeutic research. If you are interested in therapeutically relevant targets, you may want to refer to the active form of the gene PAICS, which encodes a bifunctional enzyme involved in purine biosynthesis, but PAICSP5 itself is not functionally relevant.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase pseudogene 5 (PAICSP5).